Table 2 Characteristics of patients and DILs.

From: Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study

Characteristics

Value

Age (years)

Median (range)

66 (56–82)

PSA (ng/mL)

Median (range)

5.6 (3–10.6)

T stage

2a

10

2b

1

2c

4

Gleason score

6

4

7

10

9

1

Location of DILb

2aa

4

3a

1

3pa

3

5a

1

5p

2

6a

2

6p

2

8p

3

9p

1

10p

1

DIL volume (cc)

Median (range)

1.3 (0.7–6.6)

Prostate volume (cc)

Median (range)

46.2 (18.9–63.4)

DIL / prostate volume ratio

Median (range)

0.03 (0.01–1.21)

PTV volume (cc)

Median (range)

70.0 (28.8–88.0)

  1. DIL dominant intraprostatic lesion, PSA prostate specific antigen.
  2. aOne patient had a single tumor involving both 2a and 3p segments.
  3. bFour patients had two lesions in separate segments.